Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chenyan Shangguan"'
Autor:
Zhiwei Liu, Guoling Ren, Chenyan Shangguan, Lijing Guo, Zhixiong Dong, Yueyang Li, Weina Zhang, Li Zhao, Pingfu Hou, Yu Zhang, Xiuli Wang, Jun Lu, Baiqu Huang
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40943 (2012)
All-trans retinoic acid (ATRA) has been widely investigated for treatments of many cancers including prostate cancer. HOXB13, silenced in androgen receptor-negative (AR(-)) prostate cancer cells, plays a role in AR(-) prostate cancer cell growth arre
Externí odkaz:
https://doaj.org/article/2108206c76da497699d7905561fda4b1
Autor:
Yu Zhang, Ruosi Yao, Chenyan Shangguan, Weina Zhang, Yueyang Li, Baiqu Huang, Pingfu Hou, Jun Lu, Shan Zhu, Jiang Tan, Li Zhao
Publikováno v:
Journal of Cellular Biochemistry. 113:2375-2382
Histone deacetylase (HDAC) inhibitors are emerging as a novel class of anti-tumor agents and have manifested the ability to induce apoptosis of cancer cells, and a significant number of genes have been identified as potential effectors responsible fo
Autor:
Zhixiong Dong, Baiqu Huang, Pingfu Hou, Xiuli Wang, Zhiwei Liu, Yu Zhang, Jun Lu, Li Zhao, Chenyan Shangguan, Guoling Ren, Yueyang Li, Lijing Guo, Weina Zhang
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 7, p e40943 (2012)
PLoS ONE, Vol 7, Iss 7, p e40943 (2012)
All-trans retinoic acid (ATRA) has been widely investigated for treatments of many cancers including prostate cancer. HOXB13, silenced in androgen receptor-negative (AR(-)) prostate cancer cells, plays a role in AR(-) prostate cancer cell growth arre